5:01 Acquisition Corp.
Liquidated 2022-09-20- CIK 1823465
- FVAM
- IPO 2020-10-14
- $82.7M trust
- 77 filings
- IPO Size
- $82.6M
- raised at the IPO
- Trust
- $82.7M
- as of 2022-06-30
- Current Status
- Failed
- from its latest filing
- IPO Year
- 2020
- year it listed
Filings, by quarter
77 filings over 11 quarters; violet bars carry a milestone
- 20 Q3: 2 filings
- 20 Q4: 38 filings
- 21 Q1: 6 filings
- 21 Q2: 1 filing
- 21 Q3: 1 filing
- 21 Q4: 8 filings
- 22 Q1: 8 filings
- 22 Q2: 2 filings
- 22 Q3: 6 filings
- 22 Q4: 2 filings
- 23 Q1: 3 filings
S-1 filed
IPO
Liquidated
- S-1 filed 20 Q3
- IPO 20 Q4
- Liquidated 22 Q3
SPAC Overview
Where it stands on the road from S-1 to merger
Timeline Progress
About
5:01 Acquisition Corp. is a blank-check company formed to pursue an initial business combination. It intends to target early-stage companies in the biotechnology sector of the healthcare industry in North America or Europe.
Investment Focus
Biopharmaceuticals, Healthcare
Geographic Focus
North America, Europe
Key Information
As the filings state it
- IPO Date
- 2020-10-14
- Jurisdiction of Incorporation
- Delaware
- SIC
- 6770
- Failed Date
- 2022-09-20
- SPAC Ticker
- FVAM
SPAC Team
The banks on its IPO, and the team as the filings describe it
Underwriters
Extended Team Information
The team is led by 5AM venture-capital professionals with experience investing in and building life-sciences companies, including biotechnology executives, scientists and investors, and has extensive operational, investment and public-company board experience.